Approved Symbol |
Approved Name |
Location |
No. of Studies (Positive/Negative/Trend) |
Evidence[PMID] |
ADRA1A |
adrenoceptor alpha 1A |
8p21.2 |
2(0/2/0)
|
IDA[22120526]
|
EGFR |
epidermal growth factor receptor |
7p12 |
1(0/0/1)
|
IDA[10572067]
|
HMG20A |
high mobility group 20A |
15q24 |
1(1/0/0)
|
IEA
|
BCL11A |
B-cell CLL/lymphoma 11A (zinc finger protein) |
2p16.1 |
1(1/0/0)
|
IPI[19616629]
|
TYR |
tyrosinase |
11q14.3 |
1(0/1/0)
|
ISS
|
TFAP2B |
transcription factor AP-2 beta (activating enhancer binding protein 2 beta) |
6p12 |
1(0/1/0)
|
IPI[11505339]
|
ATF4 |
activating transcription factor 4 |
22q13.1 |
1(1/0/0)
|
NAS[15775988]
|
ADRA2C |
adrenoceptor alpha 2C |
4p16.3 |
1(0/1/0)
|
IPI[16605244]
|
TCF4 |
transcription factor 4 |
18q21.1 |
6(1/5/0)
|
ISS; NAS[2105528]
|
BHLHE41 |
basic helix-loop-helix family, member e41 |
12p12.1 |
3(2/1/0)
|
IPI[15193144]; ISS
|
ARNT2 |
aryl-hydrocarbon receptor nuclear translocator 2 |
15q25.1 |
1(0/1/0)
|
IPI[12239177]; ISS
|
GRIN1 |
glutamate receptor, ionotropic, N-methyl D-aspartate 1 |
9q34.3 |
3(2/1/0)
|
IEA
|
XBP1 |
X-box binding protein 1 |
22q12.1 |
3(2/1/0)
|
IDA[1903538]; TAS[22013210]
|
JAM3 |
junctional adhesion molecule 3 |
11q25 |
2(1/1/0)
|
IEA
|
ABCG1 |
ATP-binding cassette, sub-family G (WHITE), member 1 |
21q22.3 |
1(0/1/0)
|
IPI[16870176]
|
NR4A2 |
nuclear receptor subfamily 4, group A, member 2 |
2q22-q23 |
1(0/1/0)
|
IEA
|
AGTR1 |
angiotensin II receptor, type 1 |
3q24 |
1(1/0/0)
|
IPI[10993080]
|
ARNTL |
aryl hydrocarbon receptor nuclear translocator-like |
11p15 |
7(5/2/0)
|
IEA
|
OTX2 |
orthodenticle homeobox 2 |
14q22.3 |
1(1/0/0)
|
IEA
|
NOTCH4 |
notch 4 |
6p21.3 |
2(0/2/0)
|
TAS[8681805]
|
ZHX2 |
zinc fingers and homeoboxes 2 |
8q24.13 |
1(0/0/1)
|
IDA[12741956]
|
YWHAH |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta |
22q12.1-q13.1 |
3(2/0/1)
|
IPI[11953308]
|
ADRA1B |
adrenoceptor alpha 1B |
5q33.3 |
1(1/0/0)
|
IDA[22120526]
|
GCLM |
glutamate-cysteine ligase, modifier subunit |
1p21 |
1(0/0/1)
|
IEA
|
ADCY2 |
adenylate cyclase 2 (brain) |
5p15.3 |
2(1/1/0)
|
ISS
|
TAS1R3 |
taste receptor, type 1, member 3 |
1p36 |
1(0/0/1)
|
NAS[11917125]
|
BCL2 |
B-cell CLL/lymphoma 2 |
18q21.3 |
2(0/2/0)
|
IPI[9111042]
|
CHRNB2 |
cholinergic receptor, nicotinic, beta 2 (neuronal) |
1q21.3 |
1(1/0/0)
|
IEA
|
TIMELESS |
timeless circadian clock |
12q13.3 |
3(0/3/0)
|
IEA
|
FOXP2 |
forkhead box P2 |
7q31 |
2(0/2/0)
|
IEA
|
BMP6 |
bone morphogenetic protein 6 |
6p24-p23 |
1(1/0/0)
|
IDA[7811286]
|
DRD2 |
dopamine receptor D2 |
11q22-q23 |
28(8/20/0)
|
IEA
|
GAD1 |
glutamate decarboxylase 1 (brain, 67kDa) |
2q31 |
2(1/1/0)
|
IEA
|
YWHAE |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon |
17p13.3 |
1(0/1/0)
|
IPI[11953308]
|
GCLC |
glutamate-cysteine ligase, catalytic subunit |
6p12 |
1(0/1/0)
|
IEA
|
BDKRB2 |
bradykinin receptor B2 |
14q32.1-q32.2 |
1(1/0/0)
|
IPI[10993080]
|
TENM2 |
teneurin transmembrane protein 2 |
5q35 |
1(0/0/1)
|
ISS
|
ADRA2A |
adrenoceptor alpha 2A |
10q25.2 |
1(0/1/0)
|
IPI[16605244]; ISS
|
ANO2 |
anoctamin 2, calcium activated chloride channel |
12p13.3 |
1(0/1/0)
|
IEA
|
VAPA |
VAMP (vesicle-associated membrane protein)-associated protein A, 33kDa |
18p11.2 |
1(1/0/0)
|
IPI[16227268]
|
GAD2 |
glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa) |
10p13-p11.2 |
1(0/1/0)
|
IEA
|
AHR |
aryl hydrocarbon receptor |
7p15 |
1(1/0/0)
|
TAS[19538249]
|